Ceftobiprole: a clinical view.

Simple item page
dc.contributor.authorMartinez Perez-Crespo, P M
dc.contributor.authorLopez Cortes, L E
dc.date.accessioned2025-01-07T15:38:34Z
dc.date.available2025-01-07T15:38:34Z
dc.date.issued2021-09-30
dc.description.abstractCeftobiprole is a broad-spectrum, fifth-generation cephalosporin currently approved for community-acquired and non-ventilator-associated hospital-acquired pneumonia. High bactericidal and anti-biofilm activity has been exhibited in in vitro and animal models. This, together with its synergism with other antibiotics against gram-positive bacteria, makes it an ideal candidate for treatment of complex infections, such as those associated with devices or infective endocarditis. More clinical data are needed to achieve drug positioning.
dc.description.versionNo
dc.identifier.citationMartínez Pérez-Crespo PM, López Cortés LE. Ceftobiprole: a clinical view. Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):32-34.
dc.identifier.doi10.37201/req/s01.09.2021
dc.identifier.essn1988-9518
dc.identifier.pmcPMC8683001
dc.identifier.pmid34598421
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8683001/pdf
dc.identifier.unpaywallURLhttps://seq.es/wp-content/uploads/2021/10/09.pdf
dc.identifier.urihttps://hdl.handle.net/10668/27300
dc.issue.numberSuppl1
dc.journal.titleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
dc.journal.titleabbreviationRev Esp Quimioter
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.organizationSAS - Hospital Universitario Virgen de Valme
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.number32-34
dc.provenanceRealizada la curación de contenido 12/03/2025
dc.publisherSociedad Espanola de Quimioterapia
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.publisherversionhttps://seq.es/abstract/rev-esp-quimioter-2021-september-09
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectceftobiprole
dc.subjectMRSA
dc.subjectsynergy
dc.subjectanti-biofilm
dc.subject.decsAntibacterianos
dc.subject.decsTécnicas In Vitro
dc.subject.decsPreparaciones farmacéuticas
dc.subject.decsBiopelículas
dc.subject.decsHospitales
dc.subject.decsBacterias grampositivas
dc.subject.decsCefalosporinas
dc.subject.decsNeumonía
dc.subject.decsCaracterísticas de la residencia
dc.subject.decsVentiladores mecánicos
dc.subject.decsTerapéutica
dc.subject.decsInfecciones
dc.subject.decsEndocarditis
dc.subject.meshAnimals
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshCephalosporins
dc.subject.meshEndocarditis, Bacterial
dc.subject.meshGram-Positive Bacteria
dc.subject.meshAnimals
dc.subject.meshCephalosporins
dc.subject.meshMonobactams
dc.subject.meshEndocarditis
dc.subject.meshGram-Positive Bacteria
dc.subject.meshModels, Animal
dc.subject.meshPneumonia
dc.subject.meshHospitals
dc.titleCeftobiprole: a clinical view.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number34 Suppl 1

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8683001.pdf
Size:
109.46 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen de Valme
Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía